GLS and colorectal carcinoma: To identify the potential pathway regulated Nanog expression, FAO inhibitor etomoxir (ETO), glycolysis inhibitor 2-Deoxy-D-glucose (2-DG) or glutaminase inhibitor BPTES was applied in SF CRC cells.